icddr,b has started a randomised, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of anti-parasitic medicine Ivermectin in combination with antibiotic doxycycline or Ivermectin alone.

icddr,b has started a randomised, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of anti-parasitic medicine Ivermectin in combination with antibiotic doxycycline or Ivermectin alone.
By Maimunah Mohd Sharif and Leilani Farha NAIROBI, Kenya, May 13 2020 (IPS) – Public health officials are calling the “stay home” policy the sacrifice of our generation. To flatten the curve of COVID-19 infections, this call of duty is…
Chinese scientists have developed a nanometer material that can be used for liver cancer treatment, according to the Suzhou Institute of Biomedical Engineering and Technology under the Chinese Academy of Sciences Wednesday.